Interestingly, Samudio et al. [12] reported that etomoxir potentiated apoptosis induction by the Bcl-2 antagonist ABT-737 but not by the DNA-targeting drug cytarabine in AML cells, and proposed that fatty acid inhibitors could be particularly efficacious when combined with direct activators of the intrinsic apoptotic pathway. Here, BCL2 is linked to acute myeloid leukemia.